Science1 distinct publisher3 min readPublished
A modulator credited with both raising and lowering aggression in flies can now be probed one cell type at a time, some types as small as a pair of neurons, moving the story from chemical to cellular resolution.
The Scientist · Science desk

Compiled by The ScientistSomething wrong?How this is made
Specificity was the bottleneck. The design of the resource reflects that. Rather than hunting for one gene that marks one cell type, the Salk group screened several hundred engineered lines for expression patterns that partially overlapped, then used those intersections to build split-GAL4 combinations restricted to the overlap [7]. Asahina's framing is the honest version of why: "Virtually, no single gene is sufficient for specifying one single cell type" [6].
The combinatorics explain where the labor went. Take 300 lines as an illustrative reading of "several hundred": pairwise intersections number 300 x 299 / 2, or 44,850 [17]. Almost none of those pairs are useful, and no screen tells you which ones are without imaging each. The deliverable is the curated subset that survived the screen.
Two qualifiers in the coverage claim deserve to stay attached. The access is to nearly all *long-range* octopaminergic and tyraminergic neuron types [1], so cells that stay local are outside the stated scope, and "nearly all" is not a fraction anyone has to defend numerically. The thing this doesn't tell you is how much of the system's behavioral output rides on the types that did not make the cut.
The aggression result is the cleanest demonstration of why per-type access matters. Earlier work had tied octopamine signaling to both more and less aggression [9], which is the sort of literature that gets called a paradox when the unit of analysis is a molecule. With the drivers in hand, the team describes a previously uncharacterized type, ASM4, that suppresses aggression in socially isolated males and females [10]. That reframes the disagreement as heterogeneity among cells rather than inconsistency among experiments [11]. It does not close the chemical question: the authors allow that the divergence may also depend on whether a given cell signals through tyramine, octopamine, or both [11], and tyramine is octopamine's precursor, so the two are not independent knobs [3]. Whether ASM4 was silenced, activated, or both is exactly the kind of detail that sets how much weight the suppression claim can carry.
The visual work makes the same point without the historical baggage. Distinct optic-lobe-projecting types modulated optomotor stabilization and object tracking differently [12], which is Fajner's summary in one line: "one modulator, but distinct neurons, distinct jobs" [13]. Alongside that, the toolkit let the group register genetically defined types against electron-microscopy connectome data and compare male and female anatomy [8], which is the step that makes a driver line useful to someone who did not build it.
On humans, the authors are careful and so am I. Their bridge to vertebrate noradrenergic signaling rests on conserved neuromodulatory principles, not on any vertebrate measurement in this paper [14], and octopamine's status as a functional analog of noradrenaline is a description of its role in invertebrates [3]. A resource paper's value shows up in other people's experiments, on a timescale of years.
Ranked by verification strength, evidence, and original report placement.
Researchers at the Salk Institute report in Current Biology a curated set of transgenic driver strains that provide selective genetic access to nearly all long-range octopaminergic and tyraminergic neuron types in the brain of Drosophila melanogaster.
The study is titled "Cellular and functional dissection of the octopaminergic and tyraminergic system in the Drosophila brain."
Octopamine is a major biogenic amine found in invertebrates and is often described as a functional analog of vertebrate noradrenaline; tyramine is its precursor, and together the two help modulate sensory processing, social behavior and other physiological processes.
A single neuromodulator in the fly brain can influence behaviors as varied as aggression, feeding, wakefulness, memory and visual tracking.
Researchers had lacked sufficiently specific genetic access to defined octopaminergic and tyraminergic neuron types, limiting their ability to connect individual cell types with particular behaviors.
Kenta Asahina, associate professor at Salk and senior author, said: "Virtually, no single gene is sufficient for specifying one single cell type."
Distinct publishers with included, body-backed reporting in this cluster.
1 article · August 27, 2026
Follow any of these and your For You feed starts watching them — no settings page required.
science
Queens survive pesticides by loading their eggs, which makes queen survival a useless endpoint1 distinct publisher
science
267 Ubiquitin Receptors, 93 Already Diseased: A Catalog That Gives Variants a Mechanism1 distinct publisher
science
Transcription caught mid-act in fly embryos, and it does not match the test tube1 distinct publisher
product
A closed loop inside the magnet: what United Imaging's MRI brain interface can and cannot do1 distinct publisher
Evidence-backed comparisons of source perspectives and observed adoption signals. Read the methodology
Which Builder, Operator, and Investor concerns the observed source mix emphasized—not a truth score.
Evidence, demonstrated adoption, hype gap, incentives, and confidence are assessed independently, each on its own current evidence. How these are measured.
One paper, one write-up
The methodological spine is strong for its type — a peer-reviewed Current Biology study, a named senior author on the record, a named new cell type, anatomy checked against electron microscopy connectome data. The weakness is downstream of the science: everything a reader gets passes through a single trade-press retelling that reports directions of effect without a single number. ASM4 suppresses aggression in isolated flies of both sexes; how strongly, in how many animals, we are not told.
Still on the originating bench
A toolkit's value is other people's experiments, and there are none yet. Every application described — the innervation maps, the sex comparison, ASM4, the optomotor and object-tracking dissociation — was run by the group that built the lines. GEN mentions no stock center deposit, no request terms, no collaborator. That is normal for the week a paper lands, and it is also exactly why the number is low rather than absent.
Careful, until the last two paragraphs
For most of its length this reporting is unusually disciplined — "suggests," "possibly," the tyramine-versus-octopamine question left open. Then the closing turn to conserved neuromodulatory principles and future noradrenergic studies asks readers to walk from a pair of fly neurons toward human brain function on an analogy the authors themselves qualify. The overstatement is small and it is located precisely there; the aggression and vision findings are told at roughly their true size.
Announcement cadence, industry desk
Read the structure: gap in the field, institute solves it, two quotable lines from the lab, broader human relevance, next steps. That is the arc of a university communications release, reproduced by a biotech industry outlet whose readers reward translational framing. No one here is lying; the pressures simply all point the same way — toward a resource sounding usable and a fly modulator sounding like noradrenaline. There is no funder disclosure or competing-interest note in the piece to weigh against that.
Trusting one telling of one paper
We are confident about what was published and by whom — a journal, a title, a named cell type are hard to get wrong. We are much less confident about magnitude, robustness, and usability, because a single write-up with no quantities gives nothing to test. One independent account, or one outside lab working with these drivers, would move this figure more than any re-reading of the current material can.